Cancer field conundrum: Comparative effectiveness research

Wall Street Journal Health Blog, April 23, 2010

A Duke oncologist is warning that the emphasis on comparative effectiveness studies may present obstacles for the field of cancer research. At a recent American Association for Cancer Research meeting, Duke's Amy Abernethy outlined several stumbling blocks, starting with the notion that while oncology is increasingly moving towards personalized treatment, comparative effectiveness research is based on large populations. There's also a dearth of evidence to actually direct physicians to the most "medically effective and cost-effective treatment for individual patients," she said.


MOST POPULAR

SPONSORED REPORTS
SPONSORED HEADLINES

SIGN UP

FREE e-Newsletters Join the Council Subscribe to HL magazine

SPONSORSHIP & ADVERTISING

100 Winners Circle Suite 300
Brentwood, TN 37027

800-727-5257

About | Advertise | Terms of Use | Privacy Policy | Reprints/Permissions | Contact
© HealthLeaders Media 2015 a division of BLR All rights reserved.